Skip to main content

Table 4 The difference of prognostic factors between OS (−) group and OS (+) group

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

Values

OS (−)

OS (+)

Statistic(χ2)

P-value

N

34

18

  

Platelet

  

4.294

0.039

 Increase

9(26.5%)

10(55.6%)

  

 Decrease

25(73.5%)

8(44.4%)

  

D-dimer

  

1.353

0.337

 Increase

8(23.5%)

7(38.9%)

  

 Decrease

26(76.5%)

11(61.1%)

  

Gender

  

8.497

0.008

 Male

12(35.3%)

14(77.8%)

  

 Female

22(64.7%)

4(22.2%)

  

Age

  

3.059

0.072

 ≥ 62.5

14(41.2%)

12(66.7%)

  

 < 62.5

20(58.8%)

6(33.3%)

  

Smoking

  

6.540

0.013

 Past/current

27(79.4%)

8(44.4%)

  

 Never

7(20.6%)

10(55.6%)

  

Exon21

  

0.575

0.519

 No

26(76.5%)

12(66.7%)

  

 Yes

8(23.5%)

6(33.3%)

  

Exon19

  

0.001

0.605

 No

19(55.9%)

10(55.6%)

  

 Yes

15(44.1%)

8(44.4%)

  

Other diseases

  

5.967

0.016

 No

25(73.5%)

7(38.9%)

  

 Yes

9(26.5%)

11(61.1%)

  

Other treatment

  

1.549

0.172

 No

11(32.4%)

9(50%)

  

 Yes

23(67.6%)

9(50%)

  
  1. OS overall survival, OS (−) survival group, OS (+) death group